Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes
Abstract
Although it is widely accepted that T cells have a major role in specific tumour immunity, there is now much evidence that natural killer (NK) cells, which exist in many species and spontaneously lyse certain tumour cells in vitro, provide early resistance against tumour growth. Human NK-cell activity can be augmented in vitro by interferon and its inducers, including polyinosinic:polycytidylic acid (poly I:C); furthermore, NK-like activity is generated in mixed leukocyte cultures (MLCs) as is specific cytotoxic T-cell (Tc) activity. When effector cells generated in human MLCs lyse allogeneic or autologous virus-transformed or tumour cells, it has been difficult to evaluate the relative contributions of Tc and NK-like cells to the lysis because the latter, like T cells, can form rosettes with sheep erythrocytes and react with xenogeneic anti-human thymocyte serum. We report here that monoclonal antibodies against human mononuclear cell subpopulations can distinguish Tc from NK and NK-like cells. OKT3 or OKT8 monoclonal antibodies (reactive with virtually all or a subset of T cells, respectively) with complement (C') ablate MLC-generated Tc activity against allogeneic normal cells but do not decrease lysis of HLA-negative, NK-se...Continue Reading
References
Citations
Related Concepts
Related Feeds
Antibody Specificity
Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.
Cancer Biology: Molecular Imaging
Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.